wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26738598-7E81496B-8DF5-4E5B-8B42-05BC64414789
Q26738598-7E81496B-8DF5-4E5B-8B42-05BC64414789
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-7E81496B-8DF5-4E5B-8B42-05BC64414789
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
P2860
Q26738598-7E81496B-8DF5-4E5B-8B42-05BC64414789
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-7E81496B-8DF5-4E5B-8B42-05BC64414789
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e7f35ddff3606df2dc4077526fb199bc18f51bb
P2860
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.